Conference call with management to discuss the CAPTIVATE Trial will be held on February 13 at 11 am hosted by William Blair.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNTH:
- Pipeline-in-a-Product Momentum: De-Risked Autoimmune Neurology Catalyst Path Justifies Buy Rating on Claseprubart Franchise
- Dianthus price target raised to $125 from $62 at Oppenheimer
- Dianthus files $600M mixed securities shelf
- Dianthus Therapeutics: Clinical Momentum, Pipeline Expansion, and Undervalued Catalysts Support Buy Rating
- Dianthus price target raised to $63 from $56 at Truist